PPAR signaling in the control of cardiac energy metabolism

Trends in Cardiovascular Medicine

Volumn 10, Issue 6, 2000, Pages 238-245

  Barger, Philip M ^a   Kelly, Daniel P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CELL NUCLEUS RECEPTOR; FAT; LIGAND; LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHENYLEPHRINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CONTROL SYSTEM; DIET; ENERGY METABOLISM; EXERCISE; FATTY ACID OXIDATION; GENDER; GENE EXPRESSION; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HOMEOSTASIS; HUMAN; MAMMAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; STARVATION; TRANSCRIPTION REGULATION;

ANIMALS; CARDIOMEGALY; ENERGY METABOLISM; FATTY ACIDS; FETUS; GENE EXPRESSION; HOMEOSTASIS; HUMANS; LIPID METABOLISM; MITOCHONDRIA, HEART; MYOCARDIUM; OXIDATION-REDUCTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0034467428     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00077-3     Document Type: Review

References (75)

1. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36
2. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα)
3. PPARγ is required for placental, cardiac, and adipose tissue development
4. Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth
5. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization
6. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure
7. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α
8. Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart
9. Hepatocyte nuclear factor-4 activates medium chain acyl-CoA dehydrogenase gene transcription by interacting with a complex regulatory element
10. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members
11. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages
12. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat
13. Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis
14. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
15. Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle
16. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway
17. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy
18. Peroxisome proliferator-activated receptors; nuclear control of metabolism
19. The PPARα-leukotriene B4 pathway to inflammation control
20. Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice; role for nuclear receptors in cardiac and brown adipose expression
21. The role of the peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac lipid metabolism
22. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice
23. p300 functions as a coactivator for the peroxisome proliferator-activated receptor α
24. Ligand-induced peroxisome proliferator-activated receptor α conformational change
25. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
26. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
27. The peroxisome proliferator activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression
28. Effect of endurance training on lipid metabolism in women; a potential role for PPARα in the metabolic response to training
29. Expression of peroxisome proliferator-activated receptor γ (PPARγ) in rat aortic smooth muscle cells
30. Expression of peroxisome proliferator-activated receptor α (PPARα) in primary cultures of human vascular endothelial cells
31. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
32. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
33. The tissue-specific expression and developmental regulation of the two nuclear genes encoding rat mitochondrial proteins; medium-chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase
34. Inherited cardiomyopathies
35. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
36. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
37. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
38. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
39. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
40. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) promotes cardiac mitochondrial biogenesis
41. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
42. The human medium chain acyl-CoA dehydrogenase gene promoter consists of a complex arrangement of nuclear receptor response elements and Sp1 binding sites
43. A critical role for the peroxisome proliferator-activated receptor alpha (PPARα) in the cellular fasting response; the PPARα-null mouse as a model of fatty acid oxidation disorders
44. Ligand selectivity of the peroxisome proliferator-activated receptor α
45. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor α
46. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase
47. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner
48. Developmental, nutritional, and hormonal regulation of tissue-specific expression of the genes encoding various acyl-CoA dehydrogenases and α-subunit of electron transfer flavoprotein in rat
49. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor γ
50. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
51. Identification of a novel retinoid-responsive element in the promoter region of the medium chain acyl-coenzyme A dehydrogenase gene
52. Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl- α-p-chlorophenoxyisobutyrate (clofibrate) in rats
53. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
54. Nuclear hormone receptor coregulators in action; diversity for shared tasks
55. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program
56. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart
57. Expression cloning and characterization of a novel adipocyte long-chain fatty acid transport protein
58. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers; intermolecular synergy requires only the PPARγ hormone-dependent activation function
59. Adipogenesis and obesity; rounding out the big picture
60. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
61. Expression of the rat liver carnitine palmitoyltransferase I (CPT-Iα) gene is regulated by Sp1 and nuclear factor Y; chromosomal localization and promoter characterization
62. Effects of moderate hypertension on cardiac function and metabolism in the rabbit
63. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
64. Crystal structure of the ligand binding domain of the human nuclear receptor PPARγ
65. Long-term effects of fatty acids on cell viability and gene expression of neonatal cardiac myocytes
66. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes
67. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
68. Lipid metabolism in peroxisomes; enzymology, functions and dysfunctions of the fatty acid α- and β-oxidation systems in humans
69. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity
70. A canonical structure for the ligand-binding domain of nuclear receptors
71. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
72. Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Iβ gene promoters by fatty acid enzyme substrate
73. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion
74. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ
75. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor